ViewRay, Inc. (VRAYQ)
OTCMKTS: VRAYQ · Delayed Price · USD
0.0000
0.00 (0.00%)
Jul 19, 2024, 4:00 PM EDT - Market open
ViewRay Employees
ViewRay had 295 employees as of December 31, 2022. The number of employees increased by 28 or 10.49% compared to the previous year.
Employees
295
Change (1Y)
28
Growth (1Y)
10.49%
Revenue / Employee
$358,861
Profits / Employee
-$374,288
Market Cap
1.83K
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher | 122,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
| Danaher | 63,000 |
VRAYQ News
- 9 months ago - Open Letter to ViewRay Customers, Service, Software Engineers and Suppliers—Let's Preserve ViewRay Technology - Business Wire
- 9 months ago - Letter to ViewRay Lenders/Investment Bankers and Customers From Krishnan Suthanthiran, President/Founder of TeamBest Global Companies - Business Wire
- 10 months ago - Open Letter to ViewRay Customers From Krishnan Suthanthiran, President/Founder of TeamBest Global Companies - Business Wire
- 1 year ago - ViewRay® Announces Commencement of Nasdaq Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Markets - PRNewsWire
- 1 year ago - ViewRay® Files Voluntary Chapter 11 Petitions - PRNewsWire
- 1 year ago - VA Oklahoma City Healthcare System Chooses ViewRay's MRIdian® MRI-Guided Radiation Therapy System - PRNewsWire
- 1 year ago - Top 5 Health Care Stocks That Could Blast Off In May - Coherus BioSciences (NASDAQ:CHRS), Intercept Pharma (NASDAQ:ICPT) - Benzinga
- 1 year ago - ViewRay's MRIdian® to be Featured at Leading European Radiation Oncology Meeting - PRNewsWire